Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the countries listed. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
VIMFLUITY
Fifth Extension - Granted
Show more
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use
Class 5 – Pharmaceuticals & supplements
Status timeline
- 27 Sep 2022Application filedNew Application Entered
- 7 Jul 2023Assigned to an examining attorneyAssigned To Examiner
- 11 Jul 2023Office action issuedNon-Final Action Written
- 14 Sep 2023Response to office action filedTeas Response To Office Action Received
- 21 Sep 2023Office action issuedNon-Final Action Written
- 15 Nov 2023Response to office action filedTeas Response To Office Action Received
- 16 Nov 2023Approved for publicationApproved For Pub - Principal Register
- 19 Dec 2023Published for oppositionPublished For Opposition
- 13 Feb 2024Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 31 Jul 2024Statement-of-use extension 1 grantedSou Extension 1 Granted
- 16 Jan 2025Statement-of-use extension 2 grantedSou Extension 2 Granted
- 9 Jul 2025Statement-of-use extension 3 grantedSou Extension 3 Granted
All 54 events
| 2026-08-22 | Sou Extension 5 Granted |
| 2026-08-22 | Notice Of Approval Of Extension Request E-Mailed |
| 2026-08-21 | Case Assigned To Intent To Use Paralegal |
| 2026-06-29 | Sou Teas Extension Received |
| 2026-06-29 | Sou Extension 5 Filed |
| 2026-05-12 | Teas Revoke/App/Change Addr Of Atty/Dom Rep Received |
| 2026-05-12 | Attorney/Dom.rep.revoked And/Or Appointed |
| 2026-05-12 | Teas Change Of Correspondence Received |
| 2026-05-12 | Teas Withdrawal Of Attorney Received-Firm Retains |
| 2026-01-30 | Teas Revoke/App/Change Addr Of Atty/Dom Rep Received |
| 2026-01-30 | Attorney/Dom.rep.revoked And/Or Appointed |
| 2026-01-30 | Teas Change Of Correspondence Received |
| 2026-01-30 | Teas Withdrawal Of Attorney Received-Firm Retains |
| 2025-12-05 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-12-04 | Sou Teas Extension Received |
| 2025-12-04 | Sou Extension 4 Filed |
| 2025-12-04 | Sou Extension 4 Granted |
| 2025-09-11 | Teas Revoke/App/Change Addr Of Atty/Dom Rep Received |
| 2025-09-11 | Attorney/Dom.rep.revoked And/Or Appointed |
| 2025-09-11 | Teas Change Of Correspondence Received |
| 2025-09-11 | Teas Withdrawal Of Attorney Received-Firm Retains |
| 2025-07-10 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-07-09 | Sou Teas Extension Received |
| 2025-07-09 | Sou Extension 3 Filed |
| 2025-07-09 | Sou Extension 3 Granted |
| 2025-03-04 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-01-16 | Sou Teas Extension Received |
| 2025-01-16 | Sou Extension 2 Filed |
| 2025-01-16 | Sou Extension 2 Granted |
| 2024-07-31 | Sou Teas Extension Received |
| 2024-07-31 | Sou Extension 1 Filed |
| 2024-07-31 | Sou Extension 1 Granted |
| 2024-07-31 | Notice Of Approval Of Extension Request E-Mailed |
| 2024-02-13 | Noa Mailed - Sou Required From Applicant |
| 2023-12-19 | Published For Opposition |
| 2023-12-19 | Official Gazette Publication Confirmation E-Mailed |
| 2023-11-29 | Notification Of Notice Of Publication E-Mailed |
| 2023-11-16 | Approved For Pub - Principal Register |
| 2023-11-15 | Teas Response To Office Action Received |
| 2023-11-15 | Correspondence Received In Law Office |
| 2023-11-15 | Teas/Email Correspondence Entered |
| 2023-09-21 | Correspondence Received In Law Office |
| 2023-09-21 | Teas/Email Correspondence Entered |
| 2023-09-21 | Non-Final Action Written |
| 2023-09-21 | Non-Final Action E-Mailed |
| 2023-09-21 | Notification Of Non-Final Action E-Mailed |
| 2023-09-14 | Teas Response To Office Action Received |
| 2023-07-11 | Non-Final Action Written |
| 2023-07-11 | Non-Final Action E-Mailed |
| 2023-07-11 | Notification Of Non-Final Action E-Mailed |
| 2023-07-07 | Assigned To Examiner |
| 2023-03-28 | Teas Voluntary Amendment Received |
| 2022-10-11 | New Application Office Supplied Data Entered |
| 2022-09-27 | New Application Entered |
Goods & services by class
Class 5 Pharmaceuticals & supplements
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 22 Aug 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.